Literature DB >> 21760556

Retroviral delivery of platelet-derived growth factor to spinal cord progenitor cells drives the formation of intramedullary gliomas.

Jason A Ellis1, Michael Castelli, Jeffrey N Bruce, Peter Canoll, Alfred T Ogden.   

Abstract

BACKGROUND: High-grade gliomas of the spinal cord are poorly understood tumors that are very commonly associated with bad outcomes. The transforming effects of platelet-derived growth factor (PDGF) on spinal cord glial progenitor cells may play an important role in the development of these tumors.
OBJECTIVE: To investigate the possible tumor-initiating effects of PDGF overexpression in the spinal cord, we delivered a PDGF retrovirus directly into the substance of the spinal cord.
METHODS: The spinal cords of wild-type adult rats were surgically exposed and injected with 10⁶ colony-forming units of a green fluorescent protein-tagged, PDGF-expressing retrovirus. A control virus was injected to assess the cell types that become infected during retroviral delivery to the spinal cord.
RESULTS: It was observed that PDGF overexpression in the spinal cord causes morbidity from high-grade intramedullary glioma formation between 27 and 49 days after PDGF retrovirus injection. Retroviral transduction was highly efficient with 100% of injected animals displaying the tumor phenotype. The tumors produced were highly proliferative, were locally invasive, and displayed the immunophenotype of virus-targeted glial progenitor cells (Olig2+PDGFR+NG2+GFAP-).
CONCLUSION: PDGF is capable of driving glial progenitor cells within the adult spinal cord to form high-grade gliomas. Further investigation of PDGF signaling in the spinal cord is needed to better understand and treat these devastating tumors.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 21760556      PMCID: PMC3869993          DOI: 10.1227/NEU.0b013e31822ce963

Source DB:  PubMed          Journal:  Neurosurgery        ISSN: 0148-396X            Impact factor:   4.654


  27 in total

1.  Proliferation of parenchymal neural progenitors in response to injury in the adult rat spinal cord.

Authors:  S Yamamoto; N Yamamoto; T Kitamura; K Nakamura; M Nakafuku
Journal:  Exp Neurol       Date:  2001-11       Impact factor: 5.330

2.  Proliferation and differentiation of progenitor cells throughout the intact adult rat spinal cord.

Authors:  P J Horner; A E Power; G Kempermann; H G Kuhn; T D Palmer; J Winkler; L J Thal; F H Gage
Journal:  J Neurosci       Date:  2000-03-15       Impact factor: 6.167

3.  Induction of multiple brain tumours (gliomata and leptomeningeal sarcomata) in dogs by Rous sarcoma virus.

Authors:  G F Rabotti; A S Grove; R L Sellers; W R Anderson
Journal:  Nature       Date:  1966-02-26       Impact factor: 49.962

4.  PDGF autocrine stimulation dedifferentiates cultured astrocytes and induces oligodendrogliomas and oligoastrocytomas from neural progenitors and astrocytes in vivo.

Authors:  C Dai; J C Celestino; Y Okada; D N Louis; G N Fuller; E C Holland
Journal:  Genes Dev       Date:  2001-08-01       Impact factor: 11.361

5.  Surgical pathology of intramedullary spinal cord neoplasms.

Authors:  D C Miller
Journal:  J Neurooncol       Date:  2000-05       Impact factor: 4.130

Review 6.  Chemotherapy for intramedullary spinal cord tumors.

Authors:  C Balmaceda
Journal:  J Neurooncol       Date:  2000-05       Impact factor: 4.130

7.  Dose-dependent effects of platelet-derived growth factor-B on glial tumorigenesis.

Authors:  Alan H Shih; Chengkai Dai; Xiaoyi Hu; Marc K Rosenblum; Jason A Koutcher; Eric C Holland
Journal:  Cancer Res       Date:  2004-07-15       Impact factor: 12.701

8.  Transplantable canine glioma model for use in experimental neuro-oncology.

Authors:  M Salcman; E W Scott; R S Schepp; H C Knipp; R D Broadwell
Journal:  Neurosurgery       Date:  1982-09       Impact factor: 4.654

9.  Recurrent spinal ependymoma showing partial remission under Imatimib.

Authors:  N Fakhrai; P Neophytou; K Dieckmann; A Nemeth; D Prayer; J Hainfellner; C Marosi
Journal:  Acta Neurochir (Wien)       Date:  2004-09-13       Impact factor: 2.216

10.  Intramedullary canine spinal cord tumor model.

Authors:  M Salcman; E Botero; K C Rao; R D Broadwell; E Scott
Journal:  J Neurosurg       Date:  1984-10       Impact factor: 5.115

View more
  5 in total

1.  Unique microenvironmental responses to PDGF stimulation in brain and spinal cord gliomas determine tumor phenotype.

Authors:  Jason A Ellis; Michael Castelli; Marcela Assanah; Jeffrey N Bruce; Peter Canoll; Alfred T Ogden
Journal:  J Neurooncol       Date:  2015-04-14       Impact factor: 4.130

2.  Platelet-derived growth factor receptor (PDGFR) expression in primary spinal cord gliomas.

Authors:  Jason A Ellis; Peter Canoll; Paul C McCormick; Neil A Feldstein; Richard C Anderson; Peter D Angevine; Michael G Kaiser; Paul C McCormick; Jeffrey N Bruce; Alfred T Ogden
Journal:  J Neurooncol       Date:  2011-07-26       Impact factor: 4.130

3.  NG2-cells are not the cell of origin for murine neurofibromatosis-1 (Nf1) optic glioma.

Authors:  A C Solga; S M Gianino; D H Gutmann
Journal:  Oncogene       Date:  2013-01-14       Impact factor: 9.867

4.  Candidate pathways for promoting differentiation or quiescence of oligodendrocyte progenitor-like cells in glioma.

Authors:  Joseph D Dougherty; Elena I Fomchenko; Afua A Akuffo; Eric Schmidt; Karim Y Helmy; Elena Bazzoli; Cameron W Brennan; Eric C Holland; Ana Milosevic
Journal:  Cancer Res       Date:  2012-08-03       Impact factor: 12.701

5.  Lentiviral-Induced Spinal Cord Gliomas in Rat Model.

Authors:  Purva P Nagarajan; Muhibullah S Tora; Stewart G Neill; Thais Federici; Pavlos Texakalidis; Anthony Donsante; Peter Canoll; Kecheng Lei; Nicholas M Boulis
Journal:  Int J Mol Sci       Date:  2021-11-30       Impact factor: 5.923

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.